China NMPA Product Recall - Electronic upper gastrointestinal endoscope

On July 14, 2023, the National Medical Products Administration (NMPA) announced a voluntary Class III recall initiated by Olympus Medical Products Corporation. This action, reported by Olympus Trading (Shanghai) Co., Ltd., primarily involves several electronic medical devices, including various models of electronic gastroscopes, colonoscopes, duodenoscopes, and upper gastrointestinal endoscopes. The main issue identified leading to this recall is the absence of established final inspection work standards for some of these products. This deficiency indicates a gap in the quality assurance processes intended to ensure product conformance prior to market release. Operating within the NMPA's regulatory framework for medical devices in China, Olympus is proactively taking this measure to address the non-conformance. A Class III recall typically signifies that the use of or exposure to the affected product is not likely to cause adverse health consequences. This voluntary recall demonstrates the company's commitment to upholding product safety and regulatory compliance by withdrawing potentially compromised batches from circulation.